The Latest Headlines at American Banking and Market News
TriMas (TRS) Scheduled to Post Quarterly Earnings on Tuesday
TriMas (NASDAQ:TRS – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, April 30th. Analysts expect TriMas to post earnings of $0.29 per share for the quarter. TriMas... More of this article »
Nisa Investment Advisors LLC Sells 1,825 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)
Nisa Investment Advisors LLC lowered its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) by 36.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission.... More of this article »
Nisa Investment Advisors LLC Has $27,000 Stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
Nisa Investment Advisors LLC reduced its stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 43.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange... More of this article »
Nisa Investment Advisors LLC Boosts Stake in BioLife Solutions, Inc. (NASDAQ:BLFS)
Nisa Investment Advisors LLC boosted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 167.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 1,630 shares of the medical equipment... More of this article »
Nisa Investment Advisors LLC Buys 1,006 Shares of Tucows Inc. (NASDAQ:TCX)
Nisa Investment Advisors LLC grew its stake in Tucows Inc. (NASDAQ:TCX – Free Report) (TSE:TC) by 16,766.7% during the 4th quarter, HoldingsChannel reports. The fund owned 1,012 shares of the information services provider’s... More of this article »
Nisa Investment Advisors LLC Sells 1,705 Shares of Bloom Energy Co. (NYSE:BE)
Nisa Investment Advisors LLC reduced its stake in shares of Bloom Energy Co. (NYSE:BE – Free Report) by 49.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm... More of this article »
American Assets Trust (AAT) to Release Quarterly Earnings on Tuesday
American Assets Trust (NYSE:AAT – Get Free Report) is scheduled to release its earnings data after the market closes on Tuesday, April 30th. Analysts expect American Assets Trust to post earnings of $0.60 per share for the quarter.... More of this article »
Nisa Investment Advisors LLC Takes $27,000 Position in CS Disco, Inc. (NYSE:LAW)
Nisa Investment Advisors LLC purchased a new stake in CS Disco, Inc. (NYSE:LAW – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased... More of this article »
Denny’s (DENN) to Release Earnings on Tuesday
Denny’s (NASDAQ:DENN – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, April 30th. Analysts expect the company to announce earnings of $0.14 per share for the quarter.... More of this article »
Nisa Investment Advisors LLC Increases Position in Weis Markets, Inc. (NYSE:WMK)
Nisa Investment Advisors LLC lifted its position in shares of Weis Markets, Inc. (NYSE:WMK – Free Report) by 93.2% in the 4th quarter, Holdings Channel.com reports. The firm owned 425 shares of the company’s stock after... More of this article »
Sysco (SYY) Scheduled to Post Quarterly Earnings on Tuesday
Sysco (NYSE:SYY – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Tuesday, April 30th. Analysts expect Sysco to post earnings of $0.95 per share for the quarter. Sysco has... More of this article »
Green Plains Inc. (NASDAQ:GPRE) Shares Sold by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC lessened its stake in Green Plains Inc. (NASDAQ:GPRE – Free Report) by 40.9% in the 4th quarter, Holdings Channel reports. The firm owned 1,070 shares of the specialty chemicals company’s stock... More of this article »
Nisa Investment Advisors LLC Buys 2,281 Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
Nisa Investment Advisors LLC raised its stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 417.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission.... More of this article »